Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETA-TAVI: Beta-blocker Continuation vs Interruption in TAVI
NCT05721170Phase 4Recruiting
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jun 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of carvedilol in aortic valve stenosis (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Permanent pacemaker implantation at 7 days. Started Jun 2024; status: recruiting.
02
Drugs
carvedilol
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT05721170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05721170.